Search
for
Sort by
Research 961–990 of 1000+
- Androgenetic alopecia: pathogenesis and potential for therapy
- Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors
- Two Phase 3 Trials of Baricitinib for Alopecia Areata
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- Epidermal Wnt/β-catenin signaling regulates adipocyte differentiation via secretion of adipogenic factors
- Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02
- Male androgenetic alopecia
- Follicular miniaturization in female pattern hair loss: clinicopathological correlations
- Management of primary cicatricial alopecias: options for treatment
- Treatment of alopecia areata: An Australian expert consensus statement
- Role of genetics and sex steroid hormones in male androgenetic alopecia and female pattern hair loss: An update of what we now know
- Epidemiology of skin cancer in the mature patient
- There is no clear association between low serum ferritin and chronic diffuse telogen hair loss
- Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone
- Androgenetic alopecia in men and women
- Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness
- Hair colouring, permanent styling and hair structure
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- Permanent alopecia following chemotherapy and bone marrow transplantation
- Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study
- Drugs and Hair Loss
- Chronic telogen effluvium: A study of 5 patients over 7 years
- A review of the treatment of male pattern hair loss
- Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: A randomized clinical trial
- Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss.
- Finasteride for female androgenetic alopecia
- Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Optimal Management of Hair Loss (Alopecia) in Children
- Primary cicatricial alopecia: diagnosis and treatment